Best TMS Alternatives for Depression (2026)

Transcranial magnetic stimulation (TMS) helps a meaningful share of people with depression who haven't responded to standard antidepressants, but it isn't the right fit for everyone. Some people can't commit to the standard 36-session, six-week course. Some don't respond to it. Some want to know what else exists before starting a six-week daily commitment in the first place. This guide covers five real alternatives — medication changes, ketamine/Spravato, ECT, psychotherapy, and trial-stage psilocybin data — ranked by evidence, speed, and how invasive each one is.

Why people look for TMS alternatives

TMS helps a meaningful share of patients with treatment-resistant depression, but it has real constraints that lead people to look elsewhere:

• Insurance sequencing — most plans and Medicare only cover TMS after you've failed two or more antidepressant trials, so the "alternative" many people actually need first is a different medication strategy.
• Time commitment — a standard course is about 36 sessions, five days a week for roughly six weeks; not everyone can attend daily visits for that long.
• Incomplete response — TMS helps many people, but not everyone reaches remission, and some want a faster or more intensive option.
• Severity — for depression with psychotic features or acute suicide risk, TMS's gradual (weeks-long) response curve may not be fast enough.
• Eligibility — a history of seizures or certain metal implants near the head can rule TMS out entirely.

1. Switching or augmenting medication — usually the step before TMS, not after

Before TMS is typically considered, most treatment guidelines call for trying (or combining) two or more antidepressants — a different SSRI/SNRI, or augmenting with an atypical antipsychotic or lithium. The landmark STAR*D trial tracked exactly this progression and found that remission rates fall with each successive medication step, which is part of why device-based options like TMS exist for people who don't respond to several med trials.⁴

The tradeoff is the same one that makes people look past medication in the first place: each trial takes 4–8 weeks to judge properly, and diminishing returns set in the more medications you've already tried.

Best for: Anyone who hasn't yet tried two or more adequate medication trials — this is usually the guideline-recommended step before TMS, not a true alternative to it.

2. Spravato (esketamine) / ketamine — fastest FDA-approved alternative

Spravato (esketamine) is FDA-approved specifically for treatment-resistant depression, taken as a nasal spray in a certified office under observation.¹ IV and IM ketamine are used off-label in clinics. Unlike TMS's 3–6 week response curve, many people feel relief within hours to a few days.³

The tradeoff: ketamine is a Schedule III controlled substance with short-term dissociation and raised blood pressure during dosing, versus TMS's no-drug, no-scheduling profile. Spravato is often covered by insurance after failed medications; IV ketamine is usually paid out of pocket ($400–$800/session). See our full ketamine vs TMS comparison for the complete side-by-side.

Best for: Fast relief, including crisis-level depression, or when a six-week daily visit schedule isn't realistic.

3. ECT (electroconvulsive therapy) — most effective option for the most severe cases

ECT induces a brief, controlled seizure under general anesthesia and remains one of the most closely studied treatments for severe depression, including cases with psychotic features or high suicide risk where a fast, reliable response matters most. It is generally considered the most effective treatment available for the most severe depression — more so than standard TMS — which is why psychiatrists sometimes move to ECT specifically when TMS or several medication trials haven't worked.

The tradeoff is invasiveness: ECT requires anesthesia and a hospital or specialized outpatient suite, and its memory-related side effects are more established and more significant than TMS's (which are limited mostly to scalp discomfort). See our full ketamine vs ECT comparison for more on the evidence and side-effect tradeoffs.

Best for: The most severe depression — psychotic features, high suicide risk, or depression that hasn't responded to TMS, ketamine, or multiple medications.

4. CBT / psychotherapy — the non-device, non-drug option

Cognitive behavioral therapy and other evidence-based psychotherapies don't replace TMS's mechanism, but they treat the underlying depression pattern directly and are commonly combined with any of the options above rather than used as a sole substitute for treatment-resistant depression. The tradeoff is the same one that applies everywhere therapy is used: it takes active participation and typically weeks to months to build durable results, and it works best alongside — not instead of — a medical treatment for genuinely treatment-resistant depression.

Best for: Pairing with a medical treatment for durable, lasting skills — not a standalone substitute for treatment-resistant depression on its own.

5. Psilocybin — trial-stage, not legally available for depression outside a trial

COMPASS Pathways' COMP360 psilocybin achieved its primary endpoint in a Phase 3 trial for treatment-resistant depression in 2025, following an earlier Phase 2b trial (n=233) published in the New England Journal of Medicine in 2022 that showed a larger drop in depression scores in the 25 mg arm versus a low-dose "active placebo" control.⁵⁶ It is not FDA-approved for depression, and the only legal access is a clinical trial, or, where licensed, Oregon and Colorado's regulated psilocybin programs (which are not a treatment-resistant-depression pathway specifically). Read our full psilocybin guide for more on the trial timeline. Our find a clinical trial tool can help you check current enrollment.

Best for: People who want to track an emerging option or are eligible for a clinical trial — not a currently accessible treatment outside research settings.

TMS alternatives: side-by-side comparison

Which TMS alternative is right for you?

Haven't tried two or more medications yet? Start there — it's usually the guideline-recommended step before TMS, not really an alternative to it.

Want the fastest FDA-approved option? Spravato or ketamine — relief in hours to days instead of weeks.

Depression is severe, psychotic, or you're at high suicide risk? Talk to a psychiatrist about ECT — it has the strongest evidence for the most severe cases.

Want a non-drug, non-device option to pair with treatment? CBT or another evidence-based psychotherapy.

Psilocybin's trial data is worth knowing about but isn't a currently accessible depression treatment outside a clinical trial or, where licensed, Oregon/Colorado's regulated programs.